SLXN - Silexion Therapeutics Corp
1.73
0.080 4.624%
Share volume: 21,929
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$1.65
0.08
0.05%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-29-2024 | 11-14-2024 | 03-18-2025 | 05-13-2025 | 11-12-2025 | |
| Cash flow financing | 0.000 | 2.920 M | 2.184 M | 7.432 M | 8.624 M | |
| Other financing cash flows | 0.000 | 2.920 M | 2.434 M | 3.444 M | 3.540 M | |
| Cash flow | 0.000 | 251.000 K | 0.000 | 4.973 M | 0.000 | |
| Net income | -1.489 M | -11.860 M | 0.000 | -1.735 M | -3.262 M | |
| Depreciation | 0.000 | 22.000 K | -12.000 K | 4.000 K | 4.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -16.000 K | 0.000 | -6.000 K | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 16.000 K | 0.000 | 6.000 K | 0.000 | |
| Cash Change | 0.000 | 251.000 K | -742.000 K | 4.973 M | 5.781 M |